{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:51:26Z","timestamp":1772121086378,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jmgm.2020.107710","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T02:58:35Z","timestamp":1597114715000},"page":"107710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1579-2496","authenticated-orcid":false,"given":"David J.","family":"Huggins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jmgm.2020.107710_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2020.107710_bib2","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study","author":"Wang","year":"2020","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2020.107710_bib3","series-title":"Network-based Drug Repurposing for Novel Coronavirus 2019-nCoV\/SARS-CoV-2","volume":"vol. 6","author":"Zhou","year":"2020"},{"issue":"4","key":"10.1016\/j.jmgm.2020.107710_bib4","first-page":"1686","article-title":"Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia","volume":"61","author":"Afar","year":"2001","journal-title":"Canc. Res."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2020.107710_bib6","article-title":"TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets","author":"Bestle","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.jmgm.2020.107710_bib7","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1038\/s41598-018-34859-w","article-title":"Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein","volume":"8","author":"Kleine-Weber","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2020.107710_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"issue":"14","key":"10.1016\/j.jmgm.2020.107710_bib9","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.jmgm.2020.107710_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007870","article-title":"Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in\u00a0vitro","volume":"4","author":"Kam","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2020.107710_bib11","volume":"vol. 5","author":"Zang","year":"2020"},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/BJ20130101","article-title":"Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation","volume":"452","author":"Meyer","year":"2013","journal-title":"Biochem. J."},{"issue":"17","key":"10.1016\/j.jmgm.2020.107710_bib13","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"Bosch","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jmgm.2020.107710_bib14","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2020.107710_bib15","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop","volume":"432","author":"Jaimes","year":"2020","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jmgm.2020.107710_bib16","article-title":"A\u00a0unique protease cleavage site predicted in the spike protein of the novel pneumonia coronavirus (2019-nCoV) potentially related to viral transmissibility","author":"Wang","year":"2020","journal-title":"Virol. Sin."},{"issue":"6","key":"10.1016\/j.jmgm.2020.107710_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jmgm.2020.107710_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.07.016","article-title":"TMPRSS2: a potential target for treatment of influenza virus and coronavirus infections","volume":"142","author":"Shen","year":"2017","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.jmgm.2020.107710_bib19","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jmgm.2020.107710_bib20","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0451","article-title":"TMPRSS2 and COVID-19: serendipity or opportunity for intervention?","author":"Stopsack","year":"2020","journal-title":"Canc. Discov."},{"key":"10.1016\/j.jmgm.2020.107710_bib21","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.jmgm.2020.107710_bib22","author":"Asselta"},{"key":"10.1016\/j.jmgm.2020.107710_bib23","author":"Qi"},{"issue":"D1","key":"10.1016\/j.jmgm.2020.107710_bib24","doi-asserted-by":"crossref","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database","volume":"46","author":"Rawlings","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.jmgm.2020.107710_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm030493t","article-title":"Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G","volume":"47","author":"Maryanoff","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2020.107710_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"issue":"7","key":"10.1016\/j.jmgm.2020.107710_bib27","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/prot.24084","article-title":"Crystal structure of a supercharged variant of the human enteropeptidase light chain","volume":"80","author":"Simeonov","year":"2012","journal-title":"Proteins"},{"issue":"8","key":"10.1016\/j.jmgm.2020.107710_bib28","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/j.1742-4658.2007.05756.x","article-title":"Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family","volume":"274","author":"Kyrieleis","year":"2007","journal-title":"FEBS J."},{"issue":"27","key":"10.1016\/j.jmgm.2020.107710_bib29","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1073\/pnas.0902463106","article-title":"Structure of a serine protease poised to resynthesize a peptide bond","volume":"106","author":"Zakharova","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"D1","key":"10.1016\/j.jmgm.2020.107710_bib30","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jmgm.2020.107710_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jcc.1167","article-title":"Application of the frozen atom approximation to the GB\/SA continuum model for solvation free energy","volume":"23","author":"Guvench","year":"2002","journal-title":"J.\u00a0Comput. Chem."},{"issue":"5","key":"10.1016\/j.jmgm.2020.107710_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1006\/jmbi.2001.4516","article-title":"A\u00a0novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site","volume":"307","author":"Katz","year":"2001","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jmgm.2020.107710_bib34","article-title":"Interaction with the S1\u03b2-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors","volume":"14","author":"Wendt","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/jm701359z","article-title":"Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator","volume":"51","author":"Frederickson","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.jmgm.2020.107710_bib36","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.bmcl.2006.03.049","article-title":"Novel 5-azaindole factor VIIa inhibitors","volume":"16","author":"Riggs","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2020.107710_bib37","first-page":"5113","article-title":"(4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase","volume":"vol. 97","author":"Sperl","year":"2000"},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1021\/jm0300072","article-title":"Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution","volume":"47","author":"Wendt","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jmb.2004.09.032","article-title":"Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA)","volume":"344","author":"Katz","year":"2004","journal-title":"J.\u00a0Mol. Biol."},{"issue":"11","key":"10.1016\/j.jmgm.2020.107710_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1074-5521(01)00084-9","article-title":"Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets","volume":"8","author":"Katz","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jmgm.2020.107710_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2014 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107710_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","article-title":"New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin","volume":"661","author":"Fujii","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmgm.2020.107710_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19","author":"Hoffmann","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2020.107710_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2018.02.015","article-title":"Quantitative metrics for drug\u2013target ligandability","author":"Vukovic","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2020.107710_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jmgm.2020.107710_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/MCB.26.3.965-975.2006","article-title":"Phenotypic analysis of mice lacking the Tmprss2-encoded protease","volume":"26","author":"Kim","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jmgm.2020.107710_bib47","article-title":"TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes","author":"Zang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmgm.2020.107710_bib48","article-title":"An enzymatic TMPRSS2 assay for assessment of clinical candidates and discovery of Inhibitors as potential treatment of COVID-19","author":"Shrimp","year":"2020","journal-title":"Biorxiv"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632030499X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632030499X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:09:32Z","timestamp":1761080972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332632030499X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"alternative-id":["S109332632030499X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2020.107710","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.12315449.v1","asserted-by":"object"}]},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2020.107710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107710"}}